Completed PHASE2 INTERVENTIONAL NCT00130858

a Multicenter Clinical Trial for the Treatment of Children and Adolescents With Soft Tissue Sarcoma Stage 4

Sponsor: Cooperative Weichteilsarkom Study Group

Updated 6 times since 2017 Last updated: Apr 1, 2009 Started: Jan 31, 2005 Primary completion: Dec 31, 2007 Completion: Mar 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Sarcoma, Soft Tissue, this trial is completed. The trial is conducted by Cooperative Weichteilsarkom Study Group and has accumulated 6 data snapshots since 2005. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jan 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cooperative Weichteilsarkom Study Group
Deutsche Krebshilfe e.V., Bonn (Germany)

Data source: Cooperative Weichteilsarkom Study Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Augsburg, Germany , Berlin, Germany , Bonn, Germany , Bremen, Germany , Cologne, Germany , Dresden, Germany , Düsseldorf, Germany , Erfurt, Germany , Erlangen, Germany , Essen, Germany and 25 more locations